RecallDepth
Class II Terminated

Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10 mL prefilled syringe, Item# 803, barcode 6919408031; b) 5 mL prefilled syringe, Item# 933, barcode 6919409331, Rx only, Pine Pharmaceuticals, 355 Riverwalk Parkway, Tonawanda, NY 14150.

This recall has been terminated (originally issued September 21, 2022).

Company
Pine Pharmaceuticals, Llc
Recall Initiated
July 27, 2022
Posted
September 21, 2022
Recall Number
D-1514-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 920 syringes; b) 3263 syringes
Firm Location
Tonawanda, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Product was distributed to direct accounts in AL, CA, NC and NY

Lot / Code Info

Lot #s: a) 58366, exp. date 09/26/2022; 60247, exp. date 12/04/2022; b) 54825, exp. date 08/10/2022; 57583, exp. date 08/22/2022; 59343, exp. date 10/30/2022; 60355, exp. date 10/11/2022

More recalls by Pine Pharmaceuticals, Llc

View all recalls by this company →

Other recent Class II Drug recalls